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Abstract
Background: Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV)
that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks
situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was
conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV.
Methods: A structured questionnaire was applied to elicit demographics data and farming practices considered risk
factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization
test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using
multivariate logistic regression.
Results: Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing
antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds
Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were
independently associated with anti-OPV neutralizing antibodies.
Conclusions: In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an
endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should
be applied by public health authorities to create interventions and/or prevention strategies to avoid viral
spread causing future outbreaks among individuals who are under risk of infection.
Background
Vaccinia virus (VACV) was used during mass vaccination
against smallpox leading to its eradication [1]. Routine
vaccination was ended more than 30 years ago, except for
military personnel, health assistance and laboratory
workers professionals in the United States and some parts
of Europe [2]. Although smallpox was declared eradicated
in 1980 [1], the scientific community has reassessed the
level of immunity in current populations driven by the
bioterrorism fear and also due to the emergence of zoo-
notic poxvirus around the world [3].
The emergence of zoonotic Orthopoxvirus (OPV) such
as Monkeypox virus (MPXV), which is endemic in Africa
[4, 5], but has also been accidentally introduced into the
USA [6], Cowpox virus (CPXV) in Europe [7] and Buffa-
lopox virus (BPXV) in India [8] has been frequently re-
ported. Additionally, the emergence of new zoonotic
OPVs such as Akhmeta virus [9], raises questions about
the waning population immunity against OPV which,
among other facts, could facilitate the emergence of zoo-
notic OPV. Nowadays, individuals less than 35 years
were not vaccinated against smallpox and most of those
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over 35 did not receive booster immunizations since the
early 70s. Therefore, immunity to smallpox and conse-
quently to other zoonotic OPV is considered low or
non-existent in the current populations [3, 10–16].
In Brazil, the emergence of Bovine vaccinia (VB), a
zoonotic disease caused by VACV, is associated with
rural environment and susceptible population, specially
farmers/rural workers [17–19]. Domestic animals (par-
ticularly dairy cattle) and individuals who have direct con-
tact with these animals can be affected. Nodular, ulcerated,
necrotic and painful lesions are observed mainly on hands
of infected people, due to contact with infected animals
during the milking process [13, 17]. However, lesions can
spread to secondary body sites such as forearms, arms and
face [13]. Other signs and systemic symptoms have been
also reported, such as fever, lymphadenopathy, headache
and myalgia [13]. In general, affected people are men, pre-
dominantly aged ≤40 years, although individuals >40 years
which have been vaccinated against smallpox (with pres-
ence of a vaccine take) are also affected [13, 17, 20, 21].
This fact reinforces the decrease of general immunity
against OPV.
BV presents relevant economic, social and public
health impacts. The burden of the outbreaks comprom-
ise hundreds of properties in all regions leading to sev-
eral economic losses due to decrease in milk production
and occurrence of mastitis and other secondary bacterial
infections [18, 19]. The burden of this disease is stressed
by the fact that Brazil has the largest commercial cattle
herd in the world. Furthermore, infected individuals are
unable to work due to painful lesions and overall clinical
conditions, and their families, in most times, depend on
their wage/income. There are high costs associated with
treatment and management of infected individuals and
animals, under notification of disease, misdiagnosis and
the absence of a government-enforced specific surveil-
lance policy.
This work was carried out to assess anti-OPV protect-
ive immunity of a rural population in a major dairy re-
gion in Brazil. By using this approach, only exposure
that resulted in protective humoral response (ie neutral-
izing antibody titers) was captured. Taking into account
the increasing emergence of natural OPV infections we
conducted the first epidemiological study in an endemic
BV area designed to understand risk factors associated
with OPV infection and protective status of rural popu-
lations which are in major risk to acquire infection.
Methods
Study area and population
A cross sectional study was carried out from September
2012 to March 2013, using sera samples collected from
people in rural areas in Serro city (18° 36’ 17” S 43° 22’
46” W), State of Minas Gerais, Brazil (Fig. 1). Serro has
a population of 20.833 inhabitants, with 7.938 residents
in rural areas (1.508 farms) (IBGE, 2010).
Sample size calculation was performed using an ex-
pected prevalence of 50 % and confidence interval of
95 %, an accuracy of 10 % around the estimate and a
design effect of 2.0. Using Open-Epi version 2.3.1, a
minimum sample of 190 individuals was determined for
the study. Considering the possibility of loss, denial and
exclusion a sample size of 210 individuals was planned.
However, during the field work, a total of 240 individuals
were enrolled.
Monthly visits were made to dairy farms and individ-
uals from all age groups were enrolled. The participation
of individuals from small, medium and large properties
was assured. Individuals who reported to live downtown
and work in rural areas were also included.
Study measures
A structured questionnaire was applied to elicit demo-
graphics data and risk factors for BV exposure. Demo-
graphic data included age, gender, self-reported skin
color, occupation and education level. Questions about
risk factors for BV exposure were focused on contact
with cattle, horses and wild environment, practice of
milking, type of milking, and consumption of raw milk
and cheese. Additionally, a clinical inspection was
made on left arm of participants ≥ 35 years old for the
presence of smallpox vaccine scar (vaccine take),
which is strongly correlated with protection, [22].
Routine smallpox vaccination was discontinued in
Brazil in 1978 [1], then individuals with ≥ 35 years old
should have received at least one dose of smallpox
vaccine as recommended by WHO. We considered
this group of individuals as vaccinated.
Plaque reduction neutralization assay
Blood samples were collected without anticoagulants, cen-
trifuged to harvested serum, which was stored at −20 °C
until tested. A plaque reduction neutralizing test (PRNT)
was used [23, 24] to assess immunological data. To this
aim, sera were initially heated in a water bath at 56 °C for
30 min to denature complement system proteins and sub-
sequently diluted in Eagle’s Minimum Essential Medium
(MEM) (GIBCO®, USA) free of fetal bovine sera (FBS) to a
screening ratio of 1:20. Samples were added to the same
volume (1:1) of a solution containing approximately 150
plaque forming units (PFU) of VACV strain Western Re-
serve (WR) (VACV-WR is part of our collection and was
kindly provided by Dr. C. Jungwirth, from Wurzburg
University, Germany) diluted in FBS-free MEM. The final
solution (virus/serum) was homogenized and incubated
for 16 h at 37 °C. Six-well plates (TPP®, Switzerland)
containing BSC-40 (ATCC no. CRL-2671) monolayers
with approximately 90 % confluence were inoculated with
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virus/serum solutions; plates were incubated at 37 °C for
1 h in an atmosphere supplemented with 5 % of CO2.
MEM supplemented with 2 % FBS (CULTILAB, Brazil)
was added to each well in a volume sufficient to maintain
cell monolayers during the subsequent incubation period
of 48 h at 37 °C in atmosphere supplemented with 5 % of
CO2. BSC-40 monolayers were fixed with formalin at
10 % (MERCK MILLIPORE, USA) and stained with crys-
tal violet solution at 1 % (SYNTH®, Brazil) allowing naked
eye observation of cytopathic effects. All samples were
tested in triplicate. A sample was considered positive
when the average number of PFUs was lower than half of
the PFUs counted in the virus control (at least a 50 % re-
duction in PFUs). The virus control (VC), also known as
the negative serum control, was made by using only FBS
instead of sera; and submitted to the same protocol. It was
treated as an OPV negative sample. Each six-well plate
included one well reserved for the negative serum control
and one for cell control (a negative control). A human
serum sample obtained during a previous BV outbreak
[13] was used as an OPV sera positive control.
All positive samples were titrated according to the
PRNT protocol described above. Dilutions were per-
formed in a twofold serial dilution of the sera from 1:40
to 1:5120. The last dilution in which 50 % PFU reduc-
tion was observed was used as a reference to calculate
the value of neutralizing units per milliliter (NU/mL).
The value was obtained by dividing 1 mL by the volume
of virus/serum solution inoculated on cell monolayer
and multiplying it by the least dilution that shows a
50 % reduction in PFUs.
Statistical analysis
A descriptive analysis of the results was carried out and
comparisons between those participants with and without
neutralizing antibodies were made using the Pearson's
chi-squared test. A p < 0.05 based on two-tailed alterna-
tives was considered significant. Relative odds ratios and
95 % confidence intervals were calculated. All those
variables that showed a significance level of 5 % in the uni-
variate analysis were tested again in a multiple logistic
regression model. The statistical software Epi InfoTM was
used for the analyses.
Results
Demographic profile of study population
A total of 240 individuals were enrolled in this study.
Demographic characteristics are presented in Table 1.
Fig. 1 Overview of Minas Gerais State, Brazil: a) The point marks Serro City location in Minas Gerais State. b Extended view of the urban area of Serro
City (marked in red). c Locations of the properties sampled during the course of this investigation are marked with white points (Serro outlined by the
red lines). (Google Earth, 2016)
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The median age was 38.6 years (ranging from 5 to
90 years), being most of them over 35 years that corre-
sponds to 52.5 %. Men represented 52.9 % of partici-
pants whereas women were 47.1 %. The majority
(59.2 %) had self-reported mixed skin color.
Most individuals had a low wage income (74.2 %) and
a minimum/medium education level (65 %). The rate of
illiteracy among the participants was 10 %. As expected,
a high proportion of participants worked directly in rural
activities (52.9 %), such as handling of domestic animals
and planting. Although 22.5 % had other professions,
the majority of them reported execution rural activities.
Remaining individuals were housewives and children.
Prevalence
Prevalence rates of neutralizing antibodies are presented in
Table 2. Among the 240 participants, 74 showed neutraliz-
ing antibodies, representing an overall prevalence rate of
30.8 % (CI 95 % = 25.3–36.9). Antibody titers ranged from
100 to 12.800 NU/ml. The prevalence among those classi-
fied as vaccinated individuals, using the age >35 years old
criterion, was 53.1 % (CI 95 % = 44.5 – 61.7), whereas 6.1 %
(CI 95 % = 3.0 – 12.1) of non-vaccinated, ≤35 years old cri-
terion, had detectable OPV neutralizing antibodies (p <
0.0001). If the vaccine take was used to identify the vacci-
nated group, the prevalence rates among those vaccinated
were 57.1 % (CI 95 % = 46.0 – 67.6) and among the non-
vaccinated are 18.4 % (CI 95 % = 13.2 – 25.6) (p < 0.0001).
Potential risk factors for BV exposure
Potential risk factors for BV exposure are presented in
Table 3. Among them, direct contact with domestic ani-
mals, such as bovines, equids, dogs, cats, goats and pigs
was reported by 201 individuals. Overall, 70.4 % of the
participants had contact with bovines and equids. How-
ever, during the visits to the properties, no typical BV
lesions similar to those observed during outbreaks were
seen on cattle. Almost 50 % of the participants also
Table 1 Demographic variables related to the presence of anti-OPV neutralizing antibodies
Demographics N (%) PRNT positive (%) PRNT negative (%) p value
Gender
Male 127 (52.9) 44 (34.6) 83 (65.4) 0.175
Female 113 (47.1) 30 (26.5) 83 (73.5)
Age group (years)
>35 126 (52.5) 67 (53.1) 59 (46.9) <0.0001
≤35 114 (47.5) 7 (6.2) 107 (93.8)
Self-reported skin color
Brown 142 (59.2) 44 (31.0) 98 (69.0) 0.656
Black 62 (25.8) 21 (33.9) 41 (66.1)
White 36 (15.0) 9 (25.0) 27 (75.0)
Education levela
Elementary school or less 156 (65.0) 45 (28.9) 111 (71.1) 0.032
High school or more 60 (25.0) 16 (26.7) 44 (73.3)
Have never gone to school 24 (10.0) 13 (54.1) 11 (45.9)
Residence area
Rural 208 (86.7) 63 (30.3) 145 (69.7) 0.641
Urban 32 (13.3) 11 (34.4) 21 (65.6)
Occupation
Rural workers 127 (52.9) 52 (21.0) 75 (59.0) 0.001
Housewives 59 (24.6) 15 (25.5) 44 (74.5)
Othersb 54 (22.5) 7 (13.0) 47 (87.0)
Incomec
≤1 min wage 178 (74.2) 57 (32.0) 121 (68.0) 0.178
>1 min wage 19 (7.9) 9 (47.4) 10 (52.6)
Not stated 43 (17.9) 8 (19.6) 35 (81.4)
Total 240 (100.0) 74 (30.8) 166 (69.2)
a: Elementary school or less (≤8 years of study), High school or more (>8 years of study); b: this group includes other professions such as Veterinary, Zootechnician,
Dentist, Seller and children; c: income value in Brazilian currency in 2012 = R$ 622,00 (R$ 1,00 = US$ 2,08 approximately)
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reported activities involving access to wild environment
as hunting, gathering firewood and search for cattle and
horses, which frequently run away.
Milking was an activity done by 91 individuals
(37.9 %). In this group, most individuals practiced milk-
ing (n = 60; 65.9 %) only once per day (n = 52; 57.1 %).
Consumption of unpasteurized milk and/or cheese made
from this product was reported by a high proportion of
interviewed individuals (90.4 %), whereas only 21.3 %
were involved in the cheese-making process, hereby
having direct contact with unpasteurized milk.
We determined a 35 years old based cut-off, represent-
ing the last vaccinated individuals before smallpox has
been eradicated. Using smallpox vaccination as exposure
factor, 52.5 % of interviewed individuals were vaccinated
(Table 1). Indeed, a high proportion of individuals
reporting to be vaccinated (n = 126) were considered in
fact vaccinated (n = 77, 32.1 %), due to the presence of a
vaccination scar or take on their left arm (Table 3).
Risk factors significantly linked to higher OPV
seroprevalence
The demographic characteristics significantly associated
with the presence of neutralizing antibodies in the univari-
ate analysis were age >35 years old (crude Odds Ratio =
17.3; CI 95 % = 7.4 – 40.2), illiteracy (crOR = 2.9; CI 95 % =
1.2 – 7.0), and occupation as rural workers (crOR = 2.8; CI
95 % = 1.5 – 5.1), (p < 0.05). Risk factors for BV exposure
associated with the presence of neutralizing antibodies in
the univariate analysis were contact with bovines or
equids (crOR = 2.0; CI 95 % = 1.0 – 3.8), milking (crOR =
1.7; CI 95 % = 1.0 – 3.0), participation in the cheese-mak-
ing process, (crOR = 2.4; CI 95 % = 1.3 – 4.6), have been
vaccinated as measured by the presence of vaccine take
(crOR = 5.9; CI 95 % = 3.2 – 10.7) and a previous outbreak
in property (crOR = 3.0; CI 95 % = 1.2 – 7.7), (p < 0.05).
Variables that showed significant differences between
those with positive and negative serology were analyzed
in the multivariate logistic regression model. Variables
independently associated with neutralizing antibodies
were age and previous outbreak in property. Those
older than 35 years were almost 20 times more likely
to present neutralizing antibodies than the younger
(OR = 18.2; CI 95 % = 7.7 – 43.2). Those who reported
to live or work at the property at the time of previous
outbreaks were almost four times more likely to
present neutralizing antibodies (OR = 3.9; CI 95 % =
1.2 – 12.6) than those who did not live on the farms at
that time.
Discussion
The interruption of smallpox vaccination since 1980 has
increased the susceptibility to OPV infections in human
population. Nowadays, the population majority has low
or non-existent immunity to OPV [3, 8, 18, 19]. With
concerns about the use of smallpox virus in a bioterror-
ist attack, some studies have been conducted to assess
immunity and protection of different populations against
OPV infections [24–31]. However, natural zoonotic OPV
infections which cause a burden to public health and
local economy are poorly monitored worldwide, due to a
gap in epidemiological surveillance.
Seroprevalence studies of OPV in different populations
worldwide have also been used as a marker for the status
of protection elicited by vaccination [14, 16, 23, 25, 27,
28, 30, 31]. In this study, we have assessed only anti-OPV
protective immunity (ie neutralizing antibody titers) and
our findings demonstrated that 53.1 % of presumed vacci-
nated individuals presented OPV neutralizing antibodies,
in comparison to 57.1 % of true vaccinees (represented by
those with vaccine take), a non-significant difference (p >
0.05). Similar results were observed in the United States,
in studies done by Hammarlund et al. (50 %) [25] and
Taub et al. (59.3 %) [30]; in Japan with individuals born be-
tween 1969 and 1975 (50 %) [27]; and in Italy (49-64 %),
using ELISA IgG [8]. These findings can be explained by
the fact that immunity against smallpox, and consequently
other OPVs, has been believed to persist for years, as dem-
onstrated by the studies cited above and other with mili-
tary personnel [29]. Smallpox vaccination as exposure
factor is also important to highlight. As in this study we
found that 42.9 % of true vaccinees (33/77) are seronega-
tive, we cannot assume that immunity is as long lasting as
showed elsewhere [4, 25, 27, 28, 30]. Almost half of
individuals in this category are seronegative and, indeed,
neutralizing antibodies may have been maintained in the
seropositive vaccinated individuals by continuous OPV ex-
posure, since the studied region is endemic for BV [32–34].
In addition, in the studied community, the prevalence of
neutralizing antibodies among the non-vaccinated individ-
uals was 6.1 % (using the cut-off of age >35 years old) or
18.4 %, if the absence of a vaccine take was used to identify
the non-vaccinated individuals. Also, it is important to
Table 2 Prevalence rates of neutralizing antibodies in a rural
population from Minas Gerais State, Brazil
Interviewed Prevalence rate (CI 95 %)
Overall 30.8 (25.3 - 36.9)
Vaccinateda (>35 years old) 53.1 (44.5 - 61.7)
Non-vaccinateda (≤35 years old) 6.1 (3.0 - 12.1)
Presence of vaccine takeb
Yes 57.1 (46.0 - 67.6)
No 18.4 (13.2 - 25.6)
a: Vaccinated and non-vaccinated individuals were determined according to
their age, which correspond that >35 years old participated of smallpox
eradication campaign
b: The presence of vaccine take were determined by examination on left arm
of each individual
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highlight that all seropositive non vaccinated individuals
did not present any sign of VACV infection or report
to have been infected previously. This finding rein-
forces the possibility of the existence of alternative
VACV infection routes other than the direct contact
with infected cattle [34].
The OPV seroprevalence has been used as an indicator
of wild OPV exposure/circulation [5, 14–16, 35, 36]. The
prevalence of anti-OPV neutralizing antibodies observed
in this study (30.1 %) was similar to those reported in a
retrospective study performed in 2010 in Amazon region
(27.9 %) [14], and higher when compared to 9.8 % found
in another study done with two distinct Brazilian popu-
lations [16]. Although in these two studies [14, 16] the
populations analyzed had some different characteristics
and contexts for OPV serosurvey related to our study,
other characteristics are similar, such as subsistence
agriculture and farming as the main economic activ-
ities. Another Brazilian study carried out in the State of
Rio de Janeiro showed a seropositivity of 43 % [13],
Table 3 Exposure/risk factors related to the presence of anti-OPV neutralizing antibodies
Exposure factors N (%) PRNT positive (%) PRNT negative (%) P value
Contact with bovines or equids
Yes 169 (70.4) 59 (35.0) 110 (65.0) 0.035
No 71 (29.6) 15 (21.2) 56 (78.8)
Contact with others domestic animalsa
Yes 122 (50.8) 38 (25.0) 84 (75.0) 0.915
No 118 (49.2) 36 (30.5) 82 (69.5)
Contact with wild environmentb
Yes 117 (48.8) 37 (31.6) 80 (68.4) 0.796
No 123 (51.2) 37 (31.8) 86 (68.2)
Practice milking
Yes 91 (37.9) 35 (38.5) 56 (61.5) 0.046
No 149 (62.1) 39 (26.2) 110 (73.8)
Kind of milkingc
Manual 60 (65.9) 26 (43.3) 34 (56.7) 0.193
Mechanic 31 (34.1) 9 (29.1) 22 (70.9)
Number of milkings/dayc
1/day 52 (57.1) 24 (46.2) 28 (53.8) 0.082
2/day 39 (42.9) 11 (28.2) 28 (71.8)
Raw milk/cheese consumption
Yes 217 (90.4) 70 (22.3) 147 (67.7) 0.142
No 23 (9.6) 4 (13.4) 19 (86.6)
Participate in cheese production
Yes 51 (21.3) 24 (47.1) 27 (52.9) 0.005
No 189 (78.7) 50 (26.5) 139 (73.5)
Vaccine taked
Yes 77 (32.1) 44 (57.1) 33 (42.9) <0.0001
No 163 (67.9) 30 (19.4) 133 (80.6)
Outbreak on property
Yes 20 11 (54.0) 9 (45.0) 0.015
No 220 63 (26.9) 157 (71.3)
Total 240 (100.0) 74 (30.8) 166 (69.2)
a: Other domestic animals includes cats, dogs, goats, sheeps, pigs, chickens and ducks; b: Reported by those who were in the wild environment to hunt, gather
firewood and fetch some animals of property, such as horse; c: The number of individuals in these two groups is relative to positives in practice milking group
(N = 91); d: Individuals who had a vaccine scar on left arm
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where participants were from rural properties affected
by outbreaks and most of them were infected, present-
ing clinical signs and symptoms.
Studies conducted outside Brazil, such as for BPXV in
India [10], showed a higher prevalence among rural
dwellers. Although the total number of individuals sampled
in this study was similar to ours (n = 269), 121 of them
were from rural areas that live in proximity with cattle and/
or buffaloes, which justifies the higher seroprevalence.
Although age >35 years and previous outbreak in
property were risk factors independently associated with
the presence of neutralizing antibodies (p < 0.0001), it is
impossible to distinguish if the high prevalence of neu-
tralizing antibodies among vaccinated people was due to
the background of remaining immunity from vaccina-
tions or natural infections. On the other hand, age can
be related to a higher likelihood of exposure to circulat-
ing VACV since older individuals could have had more
chances to be exposed to the virus and also because a
part of this population had direct contact with bovines
by being farm owners or practicing manual milking.
These findings are in agreement with data reported by
Lederman et al. [5] who found that age > 25 years was a
risk factor to OPV exposure.
As discussed by Kennedy et al. [22], vaccinated army has
high titers of neutralizing antibodies when vaccinated for at
least 4 years. Differently in Brazil, the population has been
vaccinated only during WHO campaign, and few individ-
uals (n = 13) presented high neutralizing antibodies titers
(6400 – 12800 UN/ml). The high neutralizing antibodies
titers found in participants >35 years and the presence of
antibodies in non-vaccinated individuals reinforce the pos-
sibility of silent VACV circulation in this population.
Unexpectedly, after adjustment by all the explanatory
variables, occupation, educational level, income, animal
handling, consumption of raw milk or cheese, cheese
production or manual milking were not associated with
presence of neutralizing antibodies. The fact that most
visited properties are small subsistence farms with
manual milking could explain the homogeneity of risks
among the studied community. A more detailed survey
in an extended area, including different farming prac-
tices is necessary to better comprehend the factors in-
volved in susceptibility and natural history of the
disease in humans and animals. BV is not a mandatory
notifiable disease in Brazil and there are few epidemio-
logical data showing prevalence and risk factors in hu-
man populations.
Conclusion
Despite the fact BV is a burden to the milk economy in
Brazil, the disease is neglected and there are still few
studies about seroprevalence in the country. In the
present study important data regarding natural OPV
circulation that is not focused on outbreaks was showed.
Our results highlight the relevance of VACV viro-
logical surveillance representing a health threat with a
high economical and medical burden. Furthermore, it
is important to know the BV exposure risks factors in
order to guide decision and recommendations to pre-
vent future outbreaks.
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